Mark Schoenberg insider trades: UroGen Pharma (URGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | URGN | ↓ Sell | 60,677 | $47.05 | $2.9M | Direct | Aug 24, 2026 (4d) |
| Jul 9, 2026 | URGN | ↓ Sell | 10,000 | $40.00 | $400K | Direct | Jul 10, 2026 (1d) |
| Jun 22, 2026 | URGN | ↓ Sell | 10,000 | $35.01 | $350K | Direct | Jun 24, 2026 (2d) |
| Jun 8, 2026 | URGN | ↓ Sell | 5,222 | $27.30 | $143K | Direct | Jun 9, 2026 (1d) |
| May 8, 2026 | URGN | ↓ Sell | 10,000 | $30.00 | $300K | Direct | May 11, 2026 (3d) |
| Feb 3, 2026 | URGN | ↓ Sell | 7,373 | $19.69 | $145K | Direct | Feb 4, 2026 (1d) |
| Nov 19, 2025 | URGN | ↓ Sell | 10,000 | $25.00 | $250K | Direct | Nov 20, 2025 (1d) |
| Sep 8, 2025 | URGN | ↓ Sell | 871 | $19.11 | $17K | Direct | Sep 9, 2025 (1d) |
| Aug 11, 2025 | URGN | ↓ Sell | 10,000 | $17.69 | $177K | Direct | Aug 13, 2025 (2d) |
| Jul 28, 2025 | URGN | ↓ Sell | 5,149 | $19.14 | $99K | Direct | Jul 30, 2025 (2d) |
| Jun 9, 2025 | URGN | ↓ Sell | 5,162 | $7.37 | $38K | Direct | Jun 11, 2025 (2d) |
| Jan 31, 2025 | URGN | ↓ Sell | 4,551 | $11.14 | $51K | Direct | Feb 4, 2025 (4d) |
| Sep 9, 2024 | URGN | ↓ Sell | 859 | $13.08 | $11K | Direct | Sep 12, 2024 (3d) |
| Jun 10, 2024 | URGN | ↓ Sell | 5,153 | $13.08 | $67K | Direct | Jun 11, 2024 (1d) |
| Mar 18, 2024 | URGN | ↓ Sell | 12,000 | $14.05 | $169K | Direct | Mar 20, 2024 (2d) |
| Jan 31, 2024 | URGN | ↓ Sell | 3,789 | $15.74 | $60K | Direct | Feb 2, 2024 (2d) |
| Jan 31, 2023 | URGN | ↓ Sell | 1,900 | $10.12 | $19K | Direct | Feb 2, 2023 (2d) |
| Oct 31, 2022 | URGN | ↓ Sell | 258 | $11.85 | $3K | Direct | Nov 2, 2022 (2d) |
| Aug 1, 2022 | URGN | ↓ Sell | 259 | $7.81 | $2K | Direct | Aug 25, 2022 (24d) |
| Apr 30, 2022 | URGN | ↓ Sell | 254 | $6.62 | $2K | Direct | May 3, 2022 (3d) |
| Jan 31, 2022 | URGN | ↓ Sell | 1,374 | $7.58 | $10K | Direct | Feb 2, 2022 (2d) |
| Jan 26, 2022 | URGN | ↓ Sell | 111 | $8.09 | $898 | Direct | Jan 28, 2022 (2d) |
| Nov 18, 2021 | URGN | ↑ Buy | 160 | $13.10 | $2K | Direct | Nov 19, 2021 (1d) |
| Nov 1, 2021 | URGN | ↓ Sell | 258 | $17.16 | $4K | Direct | Nov 2, 2021 (1d) |
| Oct 27, 2021 | URGN | ↓ Sell | 107 | $16.32 | $2K | Direct | Oct 28, 2021 (1d) |
| Aug 2, 2021 | URGN | ↓ Sell | 243 | $15.64 | $4K | Direct | Aug 3, 2021 (1d) |
| Jul 26, 2021 | URGN | ↓ Sell | 103 | $15.30 | $2K | Direct | Jul 28, 2021 (2d) |
| Apr 30, 2021 | URGN | ↓ Sell | 243 | $20.00 | $5K | Direct | May 4, 2021 (4d) |
| Apr 26, 2021 | URGN | ↓ Sell | 89 | $19.63 | $2K | Direct | Apr 27, 2021 (1d) |
| Jan 31, 2021 | URGN | ↓ Sell | 1,076 | $22.07 | $24K | Direct | Feb 2, 2021 (2d) |
| Jan 26, 2021 | URGN | ↓ Sell | 100 | $22.12 | $2K | Direct | Jan 26, 2021 (0d) |
| Dec 4, 2020 | URGN | ↓ Sell | 662 | $19.85 | $13K | Direct | Dec 7, 2020 (3d) |
| Oct 26, 2020 | URGN | ↓ Sell | 101 | $20.95 | $2K | Direct | Oct 28, 2020 (2d) |
| Sep 4, 2020 | URGN | ↓ Sell | 348 | $20.20 | $7K | Direct | Sep 8, 2020 (4d) |
| Jul 27, 2020 | URGN | ↓ Sell | 70 | $23.51 | $2K | Direct | Jul 28, 2020 (1d) |
| Jun 4, 2020 | URGN | ↓ Sell | 349 | $27.51 | $10K | Direct | Jun 5, 2020 (1d) |
| Apr 27, 2020 | URGN | ↓ Sell | 70 | $24.35 | $2K | Direct | Apr 28, 2020 (1d) |
| Jan 27, 2020 | URGN | ↓ Sell | 322 | $29.15 | $9K | Direct | Jan 28, 2020 (1d) |
| Nov 19, 2019 | URGN | ↑ Buy | 1,960 | $28.17 | $55K | By Mark Schoenberg Pension Plan FBO Mark | Nov 21, 2019 (2d) |
| Sep 4, 2019 | URGN | ↓ Sell | 343 | $33.92 | $12K | Direct | Sep 6, 2019 (2d) |
| Mar 21, 2019 | URGN | ↑ Buy | 272 | $37.01 | $10K | Direct | Mar 22, 2019 (1d) |
| Mar 6, 2019 | URGN | ↓ Sell | 1,991 | $37.30 | $74K | Direct | Mar 7, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other URGN insiders
Open-market trades in the last 12 months
About Mark Schoenberg's insider trades
Mark Schoenberg is Chief Medical Officer at UroGen Pharma (URGN). Since Mar 6, 2019, Mark has reported 3 open-market purchases worth $67K and 39 sales worth $5.3M on SEC Form 4. In the last 12 months: 7 sales ($4.4M).
Their filings also include option exercises (36 filings), grants and awards (10 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every URGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.